About Gestalt Diagnostics
Gestalt Diagnostics is a private company based in Spokane, Washington. It has reported $9,579,578 raised in three offerings on Form D since March 2017. Its chief executive is Dan Roark.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 14, 2025 | Jul 7, 2025 | $6,704,578of $9.2M target | 29 | $231K | EquityRule 506(b) | Form D ↗ |
| Jan 2, 2019 | Jan 17, 2019 | $300,000of $2.0M target | 2 | $150K | Equity, Debt, OptionsRule 506(b) | Form D ↗ |
| Feb 28, 2017 | Mar 10, 2017 | $2,575,000of $2.7M target | 39 | $66,026 | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $9,579,578 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Gestalt Diagnostics's Form D filed Jul 7, 2025.
Earlier filings also listed Wayne Wager (director, last listed Jan 2019), Ken McCabe (director, last listed Jan 2019), John Bell (director, last listed Jan 2019), David Hoak (director, last listed Jan 2019), Chris Zylak (director, last listed Jan 2019), Marco Chung (director, last listed Mar 2017) and Jon Copeland (director, last listed Mar 2017).